Publications
25. Marginal zone and follicular B cells respond differently to TLR4 and TLR9 stimulation.
Makkar H, Remick S, Roy S, Zangle TA, Roy K. BioRxiv preprint, 2025 PMID: 40475402
24. A Systems Biology Approach of Quantifying Signal Transduction to B-Cell Proliferation and Differentiation.
Roy K*, Vareli A, Mitchell S*. Methods Mol Biol., 2025 PMID: 40029522 (*Corresponding Author)
23. Tracking of lineage mass via quantitative phase imaging and confinement in low refractive index microwells
Zhang J, Griffin J, Roy K, Hoffmann A, Zangle TA. Lab Chip., 2024 PMID: 39190401
22. Direct observation correlates NFkB cRel in B-cells with activating and terminating their proliferative program.
Narayanan HV, Xiang MY, Chen Y, Huang H, Roy S, Makkar H, Hoffmann A, Roy K. PNAS, 2024 PMID: 39024115
21. The NFkB signaling system in the generation of B-cell subsets: from germinal center B cells to memory B cells and plasma cells.
Roy K*, Chakraborty M, Kumar A, Manna AK, Roy NS. Front Immunol., 2023 PMID: 38169968 (*Corresponding Author)
20. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2.
Purbey PK*, Roy K*, Gupta S, Paul MK. Mol Immunol, 2023 PMID: 36921486 (*Equal Contribution)
19. Regulation of T-independent B-cell responses by microRNA-146a.
King J, Tran T, Paing M, Yin Y, Jaiswal A, Tso C, Roy K, Casero D, Rao D. Front in Immunol, 2022 PMID: 36172375
18. COVID-19 and gut immunomodulation.
Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. World J Gastroenterol, 2021 PMID: 35046621
17. A Mimotope Attached to an ITIM-SHP-1 Interaction Inhibitory Peptide Boosts Immune Response and Efficacy.
Roy K, Roy S, Roy S. RSC Med Chem, 2021 PMID: 34223164
16. A regulatory circuit controlling the dynamics of NFkB cRel transitions B cells from proliferation to plasma cell differentiation.
Roy K*, Mitchell S*, Liu Y, Ohta S, Lin YS, Metzig M, Nutt S L and Hoffmann A. Immunity, 2019 PMID: 30850343 (*Equal Contribution)
F1000 Faculty: recommended
15. Non-genetic origins of cell-to-cell variability in B-lymphocyte proliferation.
Mitchell S*, Roy K*, Zangle TA, Hoffmann A. PNAS, 2018 PMID: 29514960 (*Equal contribution)
14. Deriving quantitative cell biological information from dye-dilution lymphocyte proliferation experiments.
Roy K, Shokhirev M, Mitchell S, Hoffmann A. Methods Mol Biol, 2018 PMID: 29388101
13. A Peptide-based Synthetic Transcription Factor Selectively Activates Transcription in a Mammalian Cell.
Roy K, Mazumder A, Ghosh P, Naiya G, Ghosh B, Roy S. Chem Commun, 2018 PMID: 29369310
12. Cholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy.
Roy K*, Mandloi S*, Chakrabarti S, Roy S. PLoS Negl Trop Dis, 2016 PMID: 27214205 (*Equal contribution)
11. Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterol.
Ghosh M*, Roy K*, Das Mukherjee D, Chakrabarti G, Roy Choudhury K, Roy S. PLoS Negl Trop Dis, 2014 PMID: 25474261 (*Equal contribution)
10. Simultaneous Inhibition of Key Growth Pathways in Melanoma Cells and Tumor Regression by a Designed Bidentate Constrained Helical Peptide.
Dhar A, Mallick S, Ghosh P, Maiti A, Ahmed I, Bhattacharya S, Mandal T, Manna A, Roy K, Singh S, Nayak DK, Wilder PT, Markowitz J, Weber D, Ghosh MK, Chattopadhyay S, Guha R, Konar A, Bandyopadhyay S, Roy S. Biopolymers, 2014 PMID: 24839139
9. Class II MHC/peptide interaction in Leishmania donovani infection: implications in vaccine design.
Roy K, Naskar K, Ghosh M, Roy S. J Immunol, 2014 PMID: 24850723
8. Cholesterol lowering drug may influence cellular immune response by altering MHC II function
Roy K, Ghosh M, Pal TK, Chakrabarti S, Roy S. J Lipid Res, 2013 PMID: 24038316
F1000 Faculty: recommended
7. Immunomodulatory effects of antileishmanial drugs.
Ghosh M, Roy K, Roy S. J Antimicrob Chemother, 2013 PMID: 23833177
6. Carrier protein influences immunodominance hierarchy: implication in vaccine design.
Ghosh M, Solanki AK, Roy K, Dhoke RR, Ashish, Roy S. Vaccine, 2013 PMID: 23928464
5. Synthesis, characterization and in vitro cytotoxicity assessment of hydroxyapatite from different bioresources for tissue engineering application.
Mondal S, Bardhan R, Mondal B, Dey A, Mukhopadhyay SS, Roy S, Guha R, Roy K. Bulletin of Material Science, 2012 August; 35(4):683-691.
4. A synthetic peptide mimic of λ-Cro shows sequence-specific binding in vitro and in vivo.
Mazumder A, Maiti A, Roy K, Roy S. ACS Chem Biol, 2012 PMID: 22480451
3. Peptide based Molecules as Protein-Protein Interaction Inhibitors: Tools for Chemical Genetics and Therapy.
Roy S, Ghosh P, Roy NS, Mazumder A, Roy K, Manna AK, Mallick S, Ahmed I. Current Chemical Biology, 2012 July; 6(2):145-163.
2. Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol.
Sen S, Roy K, Mukherjee S, Mukhopadhyay R, Roy S. PLoS Pathogen, 2011 PMID: 21931549
1. Alternative sigma factors in the free state are equilibrium mixtures of open and compact conformations.
Raha P, Chattopadhyay S, Mukherjee S, Chattopadhyay R, Roy K, Roy S. Biochemistry, 2010 PMID: 20923236